App-Quantinova.ai

Navigating therapeutic landscapes with Parkinson’s disease in a scarce biomedical healthcare setting: the case of Kenya

N. Fothergill Misbah - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Mofezolac

Not so simple: the challenge of developing a non-motor symptoms app (NMS Assist) for people with Parkinson’s (PwP)

T. Gorst - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Nurse led intrajejunal levodopa pathway for a regional neurosciences centre

P. Duggan-Carter - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Levodopa

O-arm stereotactic imaging in deep brain stimulation surgery workflow: A utility and cost-effectiveness analysis

L. Furlanetti - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

On Time, Every Time: The Effect of Cohort Ward Triage, Specialist Nursing & Admission Pre-Alert on Parkinson’s Medication Management

S. Moore - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Onset of Drug-Related Adverse Events in Parkinson’s Disease Patients with Motor Fluctuations Treated with Opicapone in Clinical Practice: OPTIPARK Post-Hoc Analysis

A. Lees - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank

D. Belete - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Patient Characteristics, Treatment Patterns and Disease Burden in People with Parkinson’s Disease: Insights from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

T. Foltynie - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Patient survey on personal preferences and choices regarding Advance Care Planning(ACP) in Parkinson’s Disease(PD)

M. Khwaja - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Plasma biomarker quantification in SCA3 using the Neurology 4-PLEX A kit and the Simoa technology

H. Garcia-Moreno - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Positive Correlations Between Quality of Life and Sleep Dysfunction in Advanced Parkinson’s Disease Patients Prior to and After 12 Months of Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis From the DUOGLOBE Study

K.R Chaudhuri - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Carbidopa and Levodopa

Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

R. Lawson - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Psychometric properties of clinical indicators of device-aided therapy eligibility among Parkinson’s disease patients: Real-world data from 6 countries

K. Chaudhuri - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Pulmonary function in Parkinson’s disease

A. O'Callaghan - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Quantification of 123I-ioflupane Striatal Uptake and Individual Patient Diagnostic Predictions: Degenerative Parkinson’s disease, Non-Degenerative Parkinsonism and Tremor Disorders

N. Heng - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Ioflupane

Real Time Quality Control for Subjective Endpoints in Clinical Trials

Y. Peng - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Slow Motion Analysis of Repetitive Tapping (SMART) test: a new means to assess bradykinesia

C. Simonet - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Twin Anaemia Polycyth aemia Syndrome

N/A

Structural and microstructural pathology in early de novo Parkinson’s disease patients with depression: An MRI study

E. de Natale - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Task based profiles of language impairment in Parkinson’s Disease

A. Lowit - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

The clinical spectrum of movement disorders associated with neuronal antibodies

V. Karthikeayan - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Movement disorders

N/A

Filters

45280 Abstracts